• Cullinan Therapeutics Chief Scientific Officer Jennifer Michaelson sold 4,000 common shares at $12.36 each on November 5, 2026.
• She also exercised stock options for 3,805 common shares at $4.3 each that day.
• Following the transactions, Michaelson directly held 158,649 common shares and 75,182 stock options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cullinan Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-452004), on November 06, 2026, and is solely responsible for the information contained therein.